Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
5.095 USD | -4.23% | -15.37% | -49.70% |
14/05 | Editas Medicine Insider Bought Shares Worth $253,868, According to a Recent SEC Filing | MT |
09/05 | Barclays Adjusts Editas Medicine Price Target to $9 From $11, Maintains Equal Weight Rating | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-49.70% | 419M | |
+48.67% | 56.69B | |
-2.76% | 41B | |
+38.00% | 38.11B | |
-11.22% | 26.89B | |
+9.25% | 25.59B | |
-23.10% | 18.59B | |
+1.88% | 12.39B | |
+26.43% | 11.99B | |
+21.74% | 11.88B |
- Stock Market
- Equities
- EDIT Stock
- News Editas Medicine, Inc.
- Editas Says EDIT-103 Shows Potential in Preclinical Data for Retinitis Pigmentosa; Shares Rise